How to calculate FFMI Fat-Free Mass Index and lean mass (EN): FFMI is the height-normalized lean mass index and is the worldwide reference for evaluating natural muscular development and for discriminating anabolic-androgenic steroid AAS use. The calculator implements the classical formula from Kouri-Pope-Katz-Hudson-Oliva McLean Hospital Belmont Massachusetts and Harvard Medical School Boston 1995 with Kouri height normalization (FFMI_adj = FFMI + 6.1*(1.8 - height_m)). Reference frameworks: NIH Bethesda, NIDA National Institute on Drug Abuse, FDA Food and Drug Administration, NHS National Health Service UK, NICE NHS England, USADA US Anti-Doping Agency Colorado Springs, WADA World Anti-Doping Agency Montreal, CAS Court of Arbitration for Sport Lausanne, NCAA National Collegiate Athletic Association Indianapolis, NFL Combine Indianapolis, NBA Draft Combine Chicago, USOC US Olympic Committee Colorado Springs.

Specialty societies: ACSM American College of Sports Medicine Indianapolis, NSCA National Strength and Conditioning Association Colorado Springs, NATA National Athletic Trainers Association Dallas, ISSN International Society Sports Nutrition, NPC National Physique Committee Pittsburgh, IFBB International Federation BodyBuilding Madrid, WNBF World Natural BodyBuilding Federation, INBA International Natural BodyBuilding Association, IFPA. Research centers: McLean Hospital Belmont Massachusetts Pope Biological Psychiatry Lab, Harvard Medical School Boston, Mayo Clinic Sports Medicine, Pennington Biomedical Research Center Baton Rouge, USC Center Body Composition. Equipment: InBody Cerritos California, Tanita Arlington Heights Illinois, SECA Hamburg, BodPod COSMED Concord California, Hologic Marlborough Massachusetts DEXA, GE Healthcare Lunar Madison Wisconsin DEXA. The FFMI 25 natural limit has become the worldwide reference threshold to discriminate natural bodybuilders from prohibited substance users WADA Code.

FFMI formula and Kouri 1995 height normalization

Fat mass kg = weight * BF%/100; lean mass kg = weight - fat mass; FFMI = lean_mass / height_m^2 (kg/m^2); Kouri normalized FFMI = FFMI + 6.1 * (1.8 - height_m). The Kouri 1995 normalization corrects FFMI to standard 1.80 m height to allow comparison across athletes of different heights: shorter subjects get inflated raw FFMI for same lean mass, so normalization adds bonus for taller subjects. Example: male 75 kg lean mass height 1.75 m: FFMI = 75/(1.75^2) = 24.49; FFMI_adj = 24.49 + 6.1*(1.8-1.75) = 24.79. FFMI Kouri-Pope 1995 categories: <17 below average, 17-20 average (sedentary or recreational), 20-22 above average (1-3 yr dedicated training), 22-25 excellent (strength athletes, advanced bodybuilders), 25-27 natural limit (rare, exceptional genetics + 10+ years), >27 suspected AAS use. For women values are 4-5 points lower (15-21 normal, 22-23 athletic). The natural ~25 limit is the historical conclusion of the Kouri 1995 paper on 157 men at McLean Hospital Belmont MA Harvard Medical School Boston.

History FFMI from Kouri-Pope 1995 to today

FFMI was introduced and popularized by the seminal paper Kouri EM, Pope HG, Katz DL, Oliva P. Fat-free mass index in users and nonusers of anabolic-androgenic steroids. Clinical Journal of Sport Medicine 5(4):223-228 1995. The study was conducted at the Biological Psychiatry Laboratory McLean Hospital Belmont Massachusetts directed by Harrison Pope, professor of psychiatry at Harvard Medical School Boston (author of The Adonis Complex 2000 on muscle dysmorphia bigorexia). The study analyzed 157 men including natural athletes and AAS users, finding a clear statistical distribution: naturals rarely exceed FFMI 25 while AAS users reach FFMI 26-32. The FFMI 25 natural limit became the worldwide reference standard for natural bodybuilding federations: WNBF World Natural Bodybuilding Federation, INBA, IFPA, USOC, NCAA, IBFF, NPC. Subsequent studies refined the limit: Hubbard 2010 showed elite genetic outliers (Mr. Olympia early 50s pre-steroid era) exceeded FFMI 28 without drugs; Schoenfeld 2018 proposed FFMI 26 as more conservative threshold. FFMI is part of diagnostic tools for muscle dysmorphia bigorexia/megaressia in APA-DSM-5 and ICD-11.

USADA US Anti-Doping, WADA Montreal, and Olympic committees use FFMI as one anthropometric indicator in suspected doping investigations. Lean mass measurement requires precision: research uses DEXA Hologic GE Lunar gold standard, clinical practice and gyms use BIA Akern InBody Tanita SECA, BodPod COSMED, hydrostatic weighing Behnke 1942, skinfold Durnin-Womersley.

Kouri-Pope 1995 FFMI categories table

5 numerical FFMI examples

Example 1 male 80 kg height 178 cm BF 15%: fat = 12 kg; lean = 68 kg; FFMI = 68/3.1684 = 21.46; FFMI_adj = 21.46 + 6.1*0.02 = 21.58 -> above average; profile 2-3 yr training.

Example 2 bodybuilder male 95 kg height 175 cm BF 8%: fat = 7.6 kg; lean = 87.4 kg; FFMI = 87.4/3.0625 = 28.54; FFMI_adj = 28.54 + 0.305 = 28.84 -> suspected AAS use; beyond Kouri 25 natural limit and outside Hubbard 28 outlier range.

Example 3 athlete male 75 kg height 180 cm BF 10%: fat = 7.5 kg; lean = 67.5 kg; FFMI = 67.5/3.24 = 20.83; FFMI_adj = 20.83 + 0 = 20.83 -> above average; swimmer or middle-distance runner profile.

Example 4 powerlifter male 110 kg height 182 cm BF 22%: fat = 24.2 kg; lean = 85.8 kg; FFMI = 85.8/3.3124 = 25.9; FFMI_adj = 25.9 - 0.122 = 25.78 -> natural limit; possible genetics + decade-long FIPL powerlifting profile.

Example 5 fitness female 60 kg height 168 cm BF 22%: fat = 13.2 kg; lean = 46.8 kg; FFMI = 46.8/2.8224 = 16.58; FFMI_adj = 16.58 + 6.1*0.12 = 17.31 -> above average female; regular fitness 2-3 sessions/week profile.

FFMI model limitations

FFMI is an estimate dependent on lean mass precision. If BF% is imprecise (BIA error +-3-5%, US Navy +-3-4%) the FFMI inherits the error (+-1-2 points). DEXA gold standard Hologic GE Lunar Mazess 1990 is recommended for validation (error +-1-2%). Overestimates in very short subjects <1.60 m even with Kouri normalization (formula calibrated on 1.80 m standard). Sex-dependent thresholds: FFMI 25 natural limit applies to men, women threshold ~22-23. Not valid in pediatric age and in subjects with hormonal abnormalities (hypogonadism, GH deficiency, Cushing syndrome). Does not distinguish lean mass type (skeletal muscle vs viscera vs bone); for sarcopenia studies ALMI Appendicular Lean Mass Index is more specific (DEXA EWGSOP2). High FFMI alone is not diagnostic of doping: some elite genetic naturals exceed 25 (Hubbard 2010 documents cases). WADA does not use FFMI as doping evidence but as suspect indicator requiring direct AAS metabolite testing or Athlete Biological Passport ABP.

Common errors

Common pitfalls: using imprecise BF% (cheap BIA error +-5-7%); confusing raw FFMI with Kouri normalized FFMI (the 25 natural limit categories apply to normalized); applying male thresholds to females ignoring 4-5 point physiological difference; expecting natural FFMI 28+ (Hubbard 2010 outliers are statistical exceptions, not reproducible); diagnosing doping from FFMI alone without biochemistry (WADA requires direct evidence); applying FFMI to pediatric age without percentiles. Confusing FFMI Fat-Free Mass Index with BMI (BMI includes fat, FFMI is lean only), with BFMI Body Fat Mass Index (fat/height^2), with SMI Skeletal Muscle Index or ALMI (DEXA only). Using FFMI as sole metric ignoring absolute strength 1RM squat bench deadlift, aerobic capacity VO2max, regional body composition.

FFMI applications USA UK worldwide

1. Natural bodybuilding: WNBF World Natural Bodybuilding Federation Cleveland Ohio, INBA International Natural Bodybuilding Association, IFPA International Federation Physique Athletes, NPC National Physique Committee Pittsburgh; UK BNBF British Natural Bodybuilding Federation; tested federations FFMI 25 natural cap reference.
2. Strength sports: USAW USA Weightlifting Colorado Springs, USAPL USA Powerlifting, USAJA USA Judo, USA Wrestling, USA Boxing; NCAA collegiate sports Indianapolis; WPA World Powerlifting Alliance; IPF International Powerlifting Federation Lulea Sweden.
3. Anti-doping: USADA US Anti-Doping Agency Colorado Springs, WADA World Anti-Doping Agency Montreal, UKAD UK Anti-Doping London, CAS Court of Arbitration for Sport Lausanne; ABP Athlete Biological Passport; WADA Code Prohibited List S1 anabolic agents.
4. Sports medicine and research: ACSM American College Sports Medicine Indianapolis, NSCA Colorado Springs, NATA Dallas, ISSN sports nutrition; McLean Hospital Belmont MA Pope Lab; Mayo Clinic Sports Medicine Rochester; Pennington Biomedical Baton Rouge; USC Center Body Composition.
5. Body composition equipment industry: InBody Cerritos CA (BIA professional), Tanita Arlington Heights IL, SECA Hamburg Germany, BodPod COSMED Concord CA, Hologic DEXA Marlborough MA, GE Healthcare Lunar DEXA Madison WI; consumer wearables Garmin Whoop Oura Apple Watch.

Updated July 2026